close

Enter

Log in using OpenID

Erythromycin Market

embed
Erythromycin Market - Size, Share, Growth,
Outlook, and Opportunity Analysis, 2018-2026
Erythromycin is an antibiotic, which is used to treat certain kind of bacterial infections. Erythromycin
topical preparations are largely used on the skin to help control acne. The antibiotic is also used in
combination with other medicines and are applied topically or taken orally for treating the infections.
The common side effects of erythromycin include nausea, loss of appetite, diarrhea, and abdominal
pain. Erythromycin prevents bacterial cells from growing and multiplying by interfering with their ability
to make proteins, while not affecting human cells. It is widely used to treat chest infections such as
pneumonia, skin problems such as acne and rosacea, dental abscesses, and sexually transmitted
infections.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/1780
Pharmaceutical manufacturers are focused on increasing access to affordable medications to provide
novel options for patients and pharmacists, thereby addressing the limited availability of erythromycin
tablets, which in turn is expected to augment market growth. For instance, in March, 2018, Amneal
Pharmaceuticals received FDA approval for Erythromycin Tablets USP, 250 mg and 500 mg
strengths. The erythromycin product is a therapeutic equivalent for the reference listed drug (RLD)
erythromycin tablets from Arbor Pharmaceuticals and is the only other immediate release oral tablet
available. Moreover, in September 2016, ANI Pharmaceuticals, Inc. launched Erythromycin
Ethylsuccinate for oral suspension 200mg/5mL indicated as a treatment for various infections
including upper and lower respiratory, skin and soft tissue, genitourinary, Legionnaires disease,
pertussis, and others.
Erythromycin Market - Regional Dynamics
Regional segmentation of the global erythromycin market by Coherent Market Insights comprises
North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America
erythromycin market is expected to hold a dominant position over the forecast period, owing to
rising number of regulatory approvals of drugs by regulatory agencies to address the unmet
medical needs of the patients and increasing prevalence of skin and soft tissue infections. For
instance, in November, 2016, Rising Pharmaceuticals, Inc.—a subsidiary of Aceto Corporation—
launched Erythromycin and Benzoyl Peroxide Topical Gel USP, 3-5% an FDA-approved generic
version of Valeant International’s Benzamycin Gel, 3-5%. According to the Division of Infectious
Diseases, Los Angeles BioMedical Research Center, 2015, skin and soft tissue infections (SSTIs)
are a common reason to seek medical care in the U.S. as they can lead to complications with
significant morbidity, including hospitalization, surgical procedures, or death.
Report includes chapters which deeply display the following deliverable about industry :
• Erythromycin Market Research Objective and Assumption
• Erythromycin Market Purview - Report Description, Executive Summary, and Coherent Opportunity
Map (COM)
• Erythromycin Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory
Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain
Analysis, Porter’s Analysis, and PEST Analysis
• Global Erythromycin Market, By Regions
• Erythromycin Market Competition by Manufacturers including Production, Share, Revenue, Average
Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Erythromycin Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Erythromycin Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers
of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Erythromycin Market Forecast including Production, Consumption, Import and Export Forecast by
Type, Applications and Region.
• Research Findings and Conclusion
Key players operating in the global erythromycin market include Ani Pharmaceuticals,
Akorn, Inc., Aceto Corporation, Genesis Pharmaceuticals, Teligent, Inc., Abbvie, Inc.,
Abbott Laboratories, Pfizer, Inc., Sanofi-Aventis, and Allergan, Plc.
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1780
Erythromycin Market Taxonomy
On the basis of formulation, the global erythromycin market is segmented into:
•
•
•
•
•
Gel
Tablet
Topical Solution
Ointment
Others
On the basis of therapeutic indications, the global erythromycin market is segmented into:
•
•
•
•
•
•
Respiratory Tract Infections
Eye Infections
Ear Infections
Skin and Soft Tissue Infections
Gastro-intestinal Infections
Others
On the basis of distribution channel, the global erythromycin market is segmented into:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
On the basis of region, the global erythromycin market is segmented into:
•
•
•
•
•
•
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Rushikesh
Rushikesh79   documents Email
Document
Category
Health and Medicine
Views
1
File Size
166 KB
Tags
market
1/--pages
Report inappropriate content